The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometry
Abstract
Fascicles of the sural nerve from each of 20 diabetic patients, mostly with maturity‐onset diabetes, were studied by biochemical and pathological techniques, and results were compared to values found in nerve specimens from 15 healthy persons. The sorbitol and fructose content was much more variable in diabetic than in healthy nerves. More than one‐third of the diabetic nerves had sorbitol and fructose values above the highest levels for controls. myo‐Inositol and scyllo‐inositol content was not reduced in diabetic nerves. The sorbitol, fructose, and inositol concentrations could not be related to clinical, neurophysiological, or pathological severity of neuropathy. A comparison of scored symptoms and signs and clinical neurophysiological studies against morphometric and teased fiber studies of sural nerve demonstrated that the former three provide sensitive and reliable measures of severity of neuropathy that can be used for controlled clinical trials of diabetic neuropathy. The presence and type of teased fiber abnormalities could be related to the duration of diabetes and to symptoms of neuropathy. In untreated diabetics without symptoms of neuropathy, a higher than normal frequency of teased fibers showing segmental demyelination and remyelination was found. Untreated diabetics with symptomatic neuropathy showed two kinds of abnormalities: fibers with segmental demyelination and remyelination and fibers undergoing axonal degeneration. In treated diabetics, who often had longstanding neuropathy, the most common abnormalities were fibers undergoing axonal degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-1-141_2 · Cited by 632
Greene, D. A., De Jesus, P. V., & Winegrad, A. I. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108052 · Cited by 466
Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes
Gabbay, K. H., Merola, L. O., & Field, R. A. (1966) · Science · doi:10.1126/science.151.3707.209 · Cited by 397
Segmental demyelination secondary to axonal degeneration in uremic neuropathy.
Pj, D., Wj, J., Lambert, E. H., & Pc, O. (1971) · PubMed · Cited by 306
myo-INOSITOL AS AN ESSENTIAL GROWTH FACTOR FOR NORMAL AND MALIGNANT HUMAN CELLS IN TISSUE CULTURE
Eagle, H., Oyama, V. I., Levy, M., & Freeman, A. E. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64820-3 · Cited by 264
Abnormal myelination in transplanted Trembler mouse Schwann cells
AGUAYO, A. J., ATTIWELL, M., TRECARTEN, J., PERKINS, S., & BRAY, G. M. (1977) · Nature · doi:10.1038/265073a0 · Cited by 224
Diabetic neuropathy: a clinical and histological study on the significance of vascular affections.
Fagerberg, S. (1959) · PubMed · Cited by 188
Ischemic Mononeuropathy Multiplex Associated With Diabetes Mellitus
RAFF, M. C., SANGALANG, V. E., & Asbury, A. K. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00470350045004 · Cited by 179
The Sorbitol Pathway: Enzyme Localization and Content in Normal and Diabetic Nerve and Cord
Gabbay, K. H., & O'Sullivan, J. B. (1968) · Diabetes · doi:10.2337/diab.17.5.239 · Cited by 175
Axonal dwindling in early experimental diabetes. I. A study of cross sectioned nerves
Jakobsen, J. (1976) · Diabetologia · doi:10.1007/bf01220629 · Cited by 173
Cited by
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., Hoang-Xuan, K., Lantéri-Minet, M., Grant, R., Huddart, R., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.012 · Cited by 583
Detection, characterization, and staging of polyneuropathy: Assessed in diabetics
Dyck, P. J. (1988) · Muscle & Nerve · doi:10.1002/mus.880110106 · Cited by 555
Self-citationTreatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis
Ziegler, D., Nowak, H., Kempler, P., Vargha, P., & Low, P. A. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01109.x · Cited by 551
Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Dyck, P. J., Daube, J., O'Brien, P., Pineda, A., Low, P. A., Windebank, A. J., & Swanson, C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140801 · Cited by 489
Self-citationMechanism of diabetic neuropathy: Where are we now and where to go?
Yagihashi, S., Mizukami, H., & Sugimoto, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00070.x · Cited by 488
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
Dyck, P. J., O'Brien, P. C., Oviatt, K. F., Dinapoli, R. P., Daube, J. R., Bartleson, J. D., Mokri, B., Swift, T., Low, P. A., & Windebank, A. J. (1982) · Annals of Neurology · doi:10.1002/ana.410110205 · Cited by 483
Self-citationDyck, P. J., Litchy, W. J., Kratz, K. M., Suarez, G. A., Low, P. A., Pineda, A. A., Windebank, A. J., Karnes, J. L., & O'Brien, P. C. (1994) · Annals of Neurology · doi:10.1002/ana.410360607 · Cited by 471
Self-citationTotal neuropathy score: Validation and reliability study
Cornblath, D. R., Chaudhry, V., Carter, K., Lee, D., Seysedadr, M., Miernicki, M., & Joh, T. (1999) · Neurology · doi:10.1212/wnl.53.8.1660 · Cited by 449
Muscle Strength in Type 2 Diabetes
Andersen, H., Nielsen, S., Mogensen, C. E., & Jakobsen, J. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1543 · Cited by 392
Dyck, P. J. B., & Windebank, A. J. (2002) · Muscle & Nerve · doi:10.1002/mus.10080 · Cited by 377
Self-citationSkin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments
Shun, C., Chang, Y., Wu, H., Hsieh, S., Lin, W., Lin, Y., Tai, T., & Hsieh, S. (2004) · Brain · doi:10.1093/brain/awh180 · Cited by 359
Amin, N., & Doupis, J. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i7.153 · Cited by 342
Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy
Dyck, P. J. B., Norell, J. E., & Dyck, P. J. (1999) · Neurology · doi:10.1212/wnl.53.9.2113 · Cited by 337
Self-citationRole of fructose in glycation and cross-linking of proteins
McPherson, J. D., Shilton, B. H., & Walton, D. J. (1988) · Biochemistry · doi:10.1021/bi00406a016 · Cited by 328
Brown, M. J., & Asbury, A. K. (1984) · Annals of Neurology · doi:10.1002/ana.410150103 · Cited by 326
Challenges of neuropathic pain: focus on diabetic neuropathy
Rosenberger, D. C., Blechschmidt, V., Timmerman, H., Wolff, A., & Treede, R.-D. (2020) · Journal of Neural Transmission · doi:10.1007/s00702-020-02145-7 · Cited by 325
Intensive evaluation of referred unclassified neuropathies yields improved diagnosis
Dyck, P. J., Oviatt, K. F., & Lambert, E. H. (1981) · Annals of Neurology · doi:10.1002/ana.410100304 · Cited by 324
Self-citationMeijer, J. W. G., Smit, A. J., Sonderen, E. V., Groothoff, J. W., Eisma, W. H., & Links, T. P. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00819.x · Cited by 322
Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic Patients
Judzewitsch, R. G., Jaspan, J. B., Polonsky, K. S., Weinberg, C. R., Halter, J. B., Halar, E., Pfeifer, M. A., Vukadinovic, C., Bernstein, L., Schneider, M., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301203080302 · Cited by 313
Schwann cell interactions with axons and microvessels in diabetic neuropathy
Gonçalves, N. P., Vægter, C. B., Andersen, H., Østergaard, L., Calcutt, N. A., & Jensen, T. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.201 · Cited by 305
Plasma Exchange in Polyneuropathy Associated with Monoclonal Gammopathy of Undetermined Significance
Dyck, P. J., Low, P. A., Windebank, A. J., Jaradeh, S. S., Gosselin, S., Bourque, P., Smith, B. E., Kratz, K. M., Karnes, J. L., Evans, B. A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252105 · Cited by 301
Self-citationFiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy
Dyck, P. J., Lais, A., Karnes, J. L., O'Brien, P., & Rizza, R. (1986) · Annals of Neurology · doi:10.1002/ana.410190503 · Cited by 298
Self-citationMalik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Pathogenesis of diabetic neuropathy
Johnson, P. C., Doll, S. C., & Cromey, D. W. (1986) · Annals of Neurology · doi:10.1002/ana.410190505 · Cited by 294
Sima, A. A. F., Bril, V., Nathaniel, V., McEwen, T. A., Brown, M. B., Lattimer, S. A., & Greene, D. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190905 · Cited by 293
A controlled study of peripheral neuropathy after bariatric surgery
Thaisetthawatkul, P., Collazo-Clavell, M. L., Sarr, M. G., Norell, J. E., & Dyck, P. J. B. (2004) · Neurology · doi:10.1212/01.wnl.0000142038.43946.06 · Cited by 280
Self-citationSural nerve oxygen tension in diabetes.
Newrick, P. G., Wilson, A. J., Jakubowski, J., Boulton, A. J., & Ward, J. D. (1986) · BMJ · doi:10.1136/bmj.293.6554.1053 · Cited by 254
Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification
Schalkwijk, C. G., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.488 · Cited by 206
Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients
Huengsberg, M., Winer, J. B., Gompels, M., Round, R., Ross, J., & Shahmanesh, M. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.4.858 · Cited by 172
Acute painful diabetic neuropathy precipitated by strict glycaemic control
Llewelyn, J. G., Thomas, P. K., Fonseca, V., King, R. H. M., & Dandona, P. (1986) · Acta Neuropathologica · doi:10.1007/bf00685978 · Cited by 121
Does this patient with diabetes have large-fiber peripheral neuropathy?
Kanji, J. N. (2010) · JAMA · doi:10.1001/jama.2010.428 · Cited by 83
Diabetes and its complications: molecular mechanisms, prevention and treatment
Zhao, L., Yuan, J., Yang, Q., Ma, J., Yang, F., Zou, Y., Liu, K., & Liu, F. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02401-w · Cited by 80
Toth, C., & Au, S. (2008) · Pain · doi:10.1016/j.pain.2008.04.023 · Cited by 37
The Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Metadata
- Authors
- Dyck, P. J., Sherman, W. R., Hallcher, L. M., John Service, F., O'Brien, P. C., Grina, L. A., Palumbo, P. J., & Swanson, C. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1980-12
- Volume
- 8
- Issue
- 6
- Pages
- 590-596
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2093206847
- Cited by
- 511
- References
- 17
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.